Evidence map›Paper›PMID 38334681›Full record

SynthesisCells2024

Brain-Type Glycogen Phosphorylase (PYGB) in the Pathologies of Diseases: A Systematic Review.

Caiting Yang, Haojun Wang, Miaomiao Shao, Fengyu Chu, Yuyu He, Xiaoli Chen, Jiahui Fan, Jingwen Chen, Qianqian Cai, Changxin Wu

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Cells, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
7.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Lactate and cognition: a dual modulator.Frontiers in molecular neuroscience · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Translational cancer research · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Caiting YangInstitutes of Biomedical Sciences, Shanxi University, Taiyuan 030006, China.
Haojun WangInstitutes of Biomedical Sciences, Shanxi University, Taiyuan 030006, China.
Miaomiao ShaoSchool of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Fengyu ChuInstitutes of Biomedical Sciences, Shanxi University, Taiyuan 030006, China.
Yuyu HeInstitutes of Biomedical Sciences, Shanxi University, Taiyuan 030006, China.
Xiaoli ChenInstitutes of Biomedical Sciences, Shanxi University, Taiyuan 030006, China.
Jiahui FanInstitutes of Biomedical Sciences, Shanxi University, Taiyuan 030006, China.
Jingwen ChenInstitutes of Biomedical Sciences, Shanxi University, Taiyuan 030006, China.
Qianqian CaiShanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai 201318, China.ORCID 0000-0002-0660-9963
Changxin WuInstitutes of Biomedical Sciences, Shanxi University, Taiyuan 030006, China.
Shanxi University · CNNanjing University of Chinese Medicine · CNShanghai University of Medicine and Health Sciences · CN

Funding

construction project of Shanghai Key Laboratory of Molecular Imaging 18DZ2260400Four "Batches" Innovation Project of Invigorating Medical through Science and Technology of Shanxi Province 2023XM028Natural Science Foundation of Shanxi Province 202203021221300Shanxi Provincial Key Laboratory of Medical Molecular Cell Biology MMCB-OP-2023-02the Natural Science Foundation of the Jiangsu Higher Education Institutions of China 20KJB310020
6 · The paper itself

Abstract

Glycogen metabolism is a form of crucial metabolic reprogramming in cells. PYGB, the brain-type glycogen phosphorylase (GP), serves as the rate-limiting enzyme of glycogen catabolism. Evidence is mounting for the association of PYGB with diverse human diseases. This review covers the advancements in PYGB research across a range of diseases, including cancer, cardiovascular diseases, metabolic diseases, nervous system diseases, and other diseases, providing a succinct overview of how PYGB functions as a critical factor in both physiological and pathological processes. We present the latest progress in PYGB in the diagnosis and treatment of various diseases and discuss the current limitations and future prospects of this novel and promising target.

Indexed as

GlycogenGlycogen PhosphorylaseBrainHumansGlycogenGlycogen Phosphorylasebrain-type glycogen phosphorylase (PYGB)glycogen metabolismglycogen phosphorylasepathology of diseases

Identifiers

PMID38334681
PMCPMC10854662
OpenAlexW4391574806

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.